Cargando…

Generation of angiostatin-like fragments from plasminogen by prostate-specific antigen

Angiostatin, a potent inhibitor of angiogenesis, tumour growth and metastasis, is a biologically active fragment of plasminogen, containing the kringle domains 1–4. It is generated from plasminogen by limited proteolysis. We show that prostate-specific antigen (PSA), a serine proteinase secreted by...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heidtmann, H-H, Nettelbeck, D M, Mingels, A, Jäger, R, Welker, H-G, Kontermann, R E
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1999
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362961/ https://www.ncbi.nlm.nih.gov/pubmed/10604721 http://dx.doi.org/10.1038/sj.bjc.6692167

Ejemplares similares

Matrix metalloproteinase-19 inhibits growth of endothelial cells by generating angiostatin-like fragments from plasminogen
por: Brauer, Rena, et al.
Publicado: (2011)

Angiostatin generating capacity and anti-tumour effects of D-penicillamine and plasminogen activators
por: de Groot-Besseling, Renate RJ, et al.
Publicado: (2006)

Linoleic acid enhances angiogenesis through suppression of angiostatin induced by plasminogen activator inhibitor 1
por: Nishioka, N, et al.
Publicado: (2011)

Circulating angiostatin serum level in patients with systemic sclerosis
por: Gerlicz-Kowalczuk, Zofia, et al.
Publicado: (2017)

Effect of Angiostatin on Liver Metastasis of Pancreatic Cancer in Hamsters
por: Yanagi, Ken, et al.
Publicado: (2000)

Regulation of the plasminogen activator system in non-small cell lung cancer cell lines by growth factors EGF, TGF-alpha and TGF-beta.
por: Heidtmann, H. H., et al.
Publicado: (1992)

Temporal and Pharmacological Characterization of Angiostatin Release and Generation by Human Platelets: Implications for Endothelial Cell Migration
por: Radziwon-Balicka, Aneta, et al.
Publicado: (2013)

Adding free to total prostate-specific antigen levels in trials of prostate cancer screening
por: Wald, N J, et al.
Publicado: (2000)

Tetranectin Binds to the Kringle 1-4 Form of Angiostatin and Modifies Its Functional Activity
por: Mogues, Tirsit, et al.
Publicado: (2004)

Treatment of medulloblastoma with oncolytic measles viruses expressing the angiogenesis inhibitors endostatin and angiostatin
por: Hutzen, Brian, et al.
Publicado: (2014)

Regulation of angiogenesis by angiostatin through immune cells and IL 12 production
por: Noonan, Douglas M, et al.
Publicado: (2006)

A Hypothesis Concerning the Biphasic Dose-response of Tumors to Angiostatin and Endostatin
por: Parris, George E.
Publicado: (2015)

Urinary angiostatin, CXCL4 and VCAM-1 as biomarkers of lupus nephritis
por: Mok, Chi Chiu, et al.
Publicado: (2018)

Associations of plasma angiostatin and amyloid-β and tau levels in Alzheimer’s disease
por: Cheng, Yuan, et al.
Publicado: (2022)

Tranexamic acid reduces endometrial cancer effects through the production of angiostatin
por: Hiramoto, Keiichi, et al.
Publicado: (2022)

Angiomotin: An Angiostatin Binding Protein That Regulates Endothelial Cell Migration and Tube Formation
por: Troyanovsky, Boris, et al.
Publicado: (2001)

Viro-antibody therapy: engineering oncolytic viruses for genetic delivery of diverse antibody-based biotherapeutics
por: Kontermann, Roland E., et al.
Publicado: (2021)

Comparison of immunohistochemistry with immunoassay (ELISA) for the detection of components of the plasminogen activation system in human tumour tissue
por: Ferrier, C M, et al.
Publicado: (1999)

Insulin-like growth factor-I and prostate cancer: a meta-analysis
por: Shi, R, et al.
Publicado: (2001)

The effect of finasteride on the prostate gland in men with elevated serum prostate-specific antigen level
por: Coltman, C A
Publicado: (1999)

Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination
por: Yu, H, et al.
Publicado: (1999)

Measurement of prostate-specific antigen in detection of benign or malignant breast disease in women
por: Romppanen, J, et al.
Publicado: (1999)

Urinary angiostatin: a novel biomarker of kidney disease associated with disease severity and progression
por: Xia, Yuan-Yuan, et al.
Publicado: (2019)

Clinical features of prostate-specific antigen bounce after (125)I brachytherapy for prostate cancer
por: Kubo, Katsumaro, et al.
Publicado: (2018)

Plasminogen activator inhibitor 1 may promote tumour growth through inhibition of apoptosis
por: Kwaan, H C, et al.
Publicado: (2000)

Expression of prostate-specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancer
por: Foekens, J A, et al.
Publicado: (1999)

Angiostatin anti-angiogenesis requires IL-12: The innate immune system as a key target
por: Albini, Adriana, et al.
Publicado: (2009)

Serum angiostatin and endostatin levels in patients with granulomatosis with polyangiitis and immune complex small vessel vasculitis
por: Kotulska-Kucharz, Anna, et al.
Publicado: (2018)

Reduction of experimental diabetic vascular leakage by delivery of angiostatin with a recombinant adeno-associated virus vector
por: Shyong, Mong-Ping, et al.
Publicado: (2007)

Maternal administration of anti-angiogenic agents, TNP-470 and Angiostatin(4.5), induces fetal microphthalmia
por: Rutland, Catrin S., et al.
Publicado: (2009)

Targeted disruption of the K-Ras oncogene in an invasive colon cancer cell line down-regulates urokinase receptor expression and plasminogen-dependent proteolysis
por: Allgayer, H, et al.
Publicado: (1999)

Processing of Laminin-5 and Its Functional Consequences: Role of Plasmin and Tissue-type Plasminogen Activator
por: Goldfinger, Lawrence E., et al.
Publicado: (1998)

Dosimetric evaluation and radioimmunotherapy of anti-tumour multivalent Fab́ fragments
por: Casey, J L, et al.
Publicado: (1999)

The topology of plasminogen binding and activation on the surface of human breast cancer cells
por: Andronicos, N M, et al.
Publicado: (2001)

Cathepsin-D, urokinase plasminogen activator and type-1 plasminogen activator inhibitor in early breast cancer: an immunohistochemical study of prognostic value and relations to tenascin-C and other factors
por: Jahkola, T, et al.
Publicado: (1999)

Prognostic value of tissue-type plasminogen activator (tPA) and its complex with the type-1 inhibitor (PAI-1) in breast cancer
por: Witte, J H de, et al.
Publicado: (1999)

Angiostatin-mediated Suppression of Cancer Metastases by Primary Neoplasms Engineered to Produce Granulocyte/Macrophage Colony–stimulating Factor
por: Dong, Zhongyun, et al.
Publicado: (1998)

Lister strain of vaccinia virus armed with endostatin-angiostatin fusion gene as a novel therapeutic agent for human pancreatic cancer
por: Tysome, James R, et al.
Publicado: (2009)

Prognostic impact of urokinase-type plasminogen activator receptor (uPAR) in cytosols and pellet extracts derived from primary breast tumours
por: Witte, J H de, et al.
Publicado: (2001)

Tobacco and marijuana use and their association with serum prostate-specific antigen levels among African American men in Chicago
por: Press, David J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_a03rp0kccj2u16bbltentgcq2s